<?xml version="1.0" encoding="UTF-8"?>
<p>Subsequently, we took these eighteen compounds and conducted a secondary screening with further validation based on their relative strengths of inhibition (at least 50%). This resulted in the selection of compound 
 <bold>35</bold>, a eugenol derivative which was utilized in further experiments.
</p>
